Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oncology Institute Inc
TOICurrent price
0.26 USD
-0.021 USD (-7.44%)
Last closed
0.26 USD
Company
theoncologyinstitute.com
ISIN
US68236X1000
Sector
Healthcare
Industry
Medical Care Facilities
Exchange
NASDAQ
Capitalization
19 627 528 USD
Yield for 12 month
-89.05 %
1Y
3Y
5Y
10Y
15Y
TOI
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. Address: 18000 Studebaker Road, Cerritos, CA, United States, 90703
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2 USDP/E ratio
–Dividend Yield
–Current Year
+324 239 000 USD
Last Year
+252 483 000 USD
Current Quarter
+98 578 000 USD
Last Quarter
+94 666 000 USD
Current Year
+53 700 000 USD
Last Year
+52 093 000 USD
Current Quarter
+11 508 000 USD
Last Quarter
+10 480 000 USD
Key Figures TOI
1 year
3 years
5 years
10 years
EBITDA
-57 338 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-19.42 %
PEG Ratio
–
Return On Equity TTM
-125.59 %
Wall Street Target Price
2 USD
Revenue TTM
361 067 008 USD
Book Value
0.39 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
22.9 %
Dividend Yield
–
Gross Profit TTM
52 093 000 USD
Earnings per share
-0.79 USD
Diluted Eps TTM
-0.79 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-19.81 %
Dividend Analytics TOI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TOI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation TOI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.2611
Price Sales TTM
0.0544
Enterprise Value EBITDA
-1.8727
Price Book MRQ
0.672
Financials TOI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TOI
For 52 weeks
0.25 USD
2.53 USD
50 Day MA
0.31 USD
Shares Short Prior Month
252 527
200 Day MA
0.85 USD
Short Ratio
4.6
Shares Short
251 810
Short Percent
0.5 %
BeatStart